I don't want to tell you my credentials online, but I'm an expert in pain (spinal and otherwise).
MSB have made an assumption which is totally incorrect, and that is that DDD causes back pain. It does not. Find yourself a professor of pain science anywhere in the world and email them this question: "does DDD cause back pain?". They'll tell you "no". MSB's stem cell program is based upon a faulty assumption. Even if the stem cells bulked up a degenerative disc to some degree, there's no way that will impact upon pain.
I have no interest in this company. I just posted this because I hate seeing such rubbish pass as legitimate research. If the SP rockets up, that's great for holders. I don't mind what the SP does.
Back pain stem cell injection, page-106
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.160(11.9%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.51 | $1.37 | $15.97M | 11.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 17522 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 4710 | 4 |
View Market Depth
| Last trade - 12.43pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |